With a lack of real breakthroughs since the 1960s, older methods such as electrical-based therapies are experiencing a revival in psychiatry.

Roche said the investment would go toward high-tech research and development sites and new manufacturing facilities in places ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

If markets lose confidence in U.S. credibility, a financial crisis could result. Europe and Switzerland should seize this opportunity now. Several key members of the U.S. president's team see the ...

European stock markets closed mostly lower in Friday trading as the Stoxx Europe 600 was off 0.10%, Germany's DAX dropped 0.92%, the FTSE 100 in London was up 0.64%, France's CAC 40 fell 0.30%, and ...

The Government of Switzerland has made a voluntary contribution of €30,000 to strengthen relations and cooperation between the Ukrainian Parliament and the Parliamentary Assembly of the Council of ...

It was followed by rival GSK, which tumbled 5.7 per cent ... Danish firm Novo Nordisk, the maker of Ozempic, dropped 6.9 per cent, while Swiss firm Roche fell 5.8 per cent, and France’s Sanofi ...

GSK recently announced the FDA approval of Blujepa, a first-in-class antibiotic for urinary tract infections, and the EMA's acceptance of an application for Nucala's expanded use. Despite these ...

You may qualify for a Canadian or a Swiss benefit, or both. However, under the Convention, the benefit paid by each country will be based solely on your creditable periods under that country's pension ...

Pfizer and GlaxoSmithKline have agreed to end a lawsuit over alleged patent infringement involving their competing respiratory syncytial virus (RSV) vaccines, according to a filing made in Delaware ...

Another institutional investor has shed a Washington, D.C.-area office building for a fraction of what it paid for it. Nuveen sold the office building at 4350 N. Fairfax Drive in Arlington ...